• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物补贴对老年人自付处方药支出的影响:来自加拿大的区域证据。

The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada.

作者信息

Alan Sule, Crossley Thomas F, Grootendorst Paul, Veall Michael R

机构信息

Department of Economics, York University, Toronto, Canada.

出版信息

J Health Econ. 2002 Sep;21(5):805-26. doi: 10.1016/s0167-6296(02)00012-7.

DOI:10.1016/s0167-6296(02)00012-7
PMID:12349883
Abstract

Between 1970 and 1986, all Canadian provinces introduced some version of a prescription drug subsidy for those aged 65 years or over and since 1986, all the provinces have increased copayments or deductibles to some degree. Employing a first-order approximation to the welfare gains from a subsidy, we find evidence that these subsidies have been less redistributive than an absolute per household cash transfer but slightly more redistributive than a transfer that would increase each household's income by the same percentage. Such evidence may have relevance for predicting the redistributive effects of a potential national prescription drug plan for seniors in the US.

摘要

1970年至1986年间,加拿大所有省份都针对65岁及以上老年人推出了某种形式的处方药补贴,自1986年以来,所有省份都在一定程度上提高了自付费用或免赔额。利用对补贴带来的福利收益的一阶近似,我们发现有证据表明,这些补贴的再分配作用不如每户绝对现金转移,但比按相同百分比增加每户收入的转移略具再分配性。这些证据可能有助于预测美国一项潜在的全国老年人处方药计划的再分配效果。

相似文献

1
The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada.药物补贴对老年人自付处方药支出的影响:来自加拿大的区域证据。
J Health Econ. 2002 Sep;21(5):805-26. doi: 10.1016/s0167-6296(02)00012-7.
2
Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.年度美元限额或“上限”对医疗保险患者处方药福利的影响。
JAMA. 2003 Jul 9;290(2):222-7. doi: 10.1001/jama.290.2.222.
3
Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.评估台湾门诊处方药共付政策对老年人的影响。
Med Care. 2003 Dec;41(12):1331-42. doi: 10.1097/01.MLR.0000100579.91550.C4.
4
Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures.省级处方药计划的比较及其对患者年度药品支出的影响。
CMAJ. 2008 Feb 12;178(4):405-9. doi: 10.1503/cmaj.070587.
5
Prescription drugs: issues of cost, coverage, and quality.处方药:成本、保险范围及质量问题。
EBRI Issue Brief. 1999 Apr(208):1-21.
6
Whither seniors' pharmacare: lessons from (and for) Canada.老年人药物治疗何去何从:来自加拿大(以及对加拿大的)经验教训
Health Aff (Millwood). 2003 May-Jun;22(3):49-59. doi: 10.1377/hlthaff.22.3.49.
7
Impact of brand drug discount cards on private insurer, government and patient expenditures.品牌药折扣卡在私人保险公司、政府和患者支出方面的影响。
CMAJ. 2019 Nov 11;191(45):E1237-E1241. doi: 10.1503/cmaj.190098.
8
By the numbers. The rising costs of prescription drugs.从数据来看。处方药成本不断上涨。
Healthplan. 1999 Sep-Oct;40(5):71-2.
9
The demand for prescription drugs as a function of cost-sharing.作为成本分摊函数的处方药需求。
Soc Sci Med. 1985;21(10):1063-9. doi: 10.1016/0277-9536(85)90161-3.
10
Employer drug benefit plans and spending on prescription drugs.雇主药物福利计划与处方药支出
JAMA. 2002 Oct 9;288(14):1733-9. doi: 10.1001/jama.288.14.1733.

引用本文的文献

1
The financial burden of out of pocket prescription drug expenses in Canada.加拿大自付处方药费用的经济负担。
Int J Health Econ Manag. 2015 Sep;15(3):329-338. doi: 10.1007/s10754-015-9171-3. Epub 2015 Mar 24.
2
Equity in dental care among Canadian households.加拿大家庭牙科保健中的公平性。
Int J Equity Health. 2011 Apr 16;10:14. doi: 10.1186/1475-9276-10-14.
3
Impact of healthcare reforms on out-of-pocket health expenditures in Turkey for public insurees.土耳其医保改革对公共保险参保者自付医疗支出的影响。
Eur J Health Econ. 2012 Jun;13(3):337-46. doi: 10.1007/s10198-011-0306-2. Epub 2011 Mar 19.
4
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.处方药费用对效率和公平有何影响?来自高收入国家的证据。
Int J Equity Health. 2008 May 2;7:12. doi: 10.1186/1475-9276-7-12.